{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:51:49Z","timestamp":1772009509148,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was supported by Otsuka Pharmaceutical Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00380-024-02397-3","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T02:01:30Z","timestamp":1715047290000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical efficacy of tolvaptan in acute decompensated heart failure patients with severe aortic stenosis and atrial fibrillation: a sub-analysis from the LOHAS registry"],"prefix":"10.1007","volume":"39","author":[{"given":"Tsutomu","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5303","authenticated-orcid":false,"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Natsumeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaku","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Nishihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Jujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"issue":"3","key":"2397_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1536\/ihj.16-226","volume":"58","author":"K Takasu","year":"2017","unstructured":"Takasu K, Miyazaki T, Negoro K, Yatsu S, Shimizu M, Murata A, Kato T, Suda S, Hiki M, Kasai T (2017) Successful treatment of congestive heart failure due to severe aortic valve stenosis with low dose tolvaptan in elderly patients. Int Heart J 58(3):378\u2013384","journal-title":"Int Heart J"},{"issue":"46","key":"2397_CR2","first-page":"3250","volume":"36","author":"D Kotecha","year":"2015","unstructured":"Kotecha D, Piccini JP (2015) Atrial fibrillation in heart failure: what should we do? Eur Heart J 36(46):3250\u20133257","journal-title":"Eur Heart J"},{"issue":"18","key":"2397_CR3","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/j.jcin.2020.05.049","volume":"13","author":"T Okuno","year":"2020","unstructured":"Okuno T, Hagemeyer D, Brugger N, Ryffel C, Heg D, Lanz J, Praz F, Stortecky S, Raber L, Roten L, Reichlin T, Windecker S, Pilgrim T (2020) Valvular and nonvalvular atrial fibrillation in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 13(18):2124\u20132133","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"2397_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40262-014-0194-6","volume":"54","author":"K Kida","year":"2015","unstructured":"Kida K, Shibagaki Y, Tominaga N, Matsumoto N, Akashi YJ, Miyake F, Kimura K (2015) Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study. Clin Pharmacokinet 54(3):273\u2013284","journal-title":"Clin Pharmacokinet"},{"issue":"395","key":"2397_CR5","first-page":"2","volume":"6","author":"H Takimura","year":"2015","unstructured":"Takimura H, Muramatsu T, Ito Y, Sakai T (2015) Efficacy and safety of coadministration of tolvaptan and carperitide for acute decompensated heart failure patients. J Clin Exp Cardiol 6(395):2","journal-title":"J Clin Exp Cardiol"},{"issue":"6","key":"2397_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cardfail.2016.02.007","volume":"22","author":"Y Matsue","year":"2016","unstructured":"Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K (2016) Clinical effectiveness of tolvaptan in patients with acute heart failure and renal dysfunction. J Card Fail 22(6):423\u2013432","journal-title":"J Card Fail"},{"key":"2397_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijcard.2020.02.017","volume":"305","author":"Y Watanabe","year":"2020","unstructured":"Watanabe Y, Nara Y, Hioki H, Kawashima H, Kataoka A, Nakashima M, Nishihata Y, Hayashida K, Yamamoto M, Tanaka J, Mizutani K, Jujo K, Nakazawa G, Izumo M, Kozuma K (2020) Short-term effects of low-dose tolvaptan in acute decompensated heart failure patients with severe aortic stenosis: the LOHAS registry. Int J Cardiol 305:82\u201386","journal-title":"Int J Cardiol"},{"issue":"3","key":"2397_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ehjci\/jew335","volume":"18","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM (2017) Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European association of cardiovascular imaging and the American society of echocardiography. Eur Heart J Cardiovasc Imaging 18(3):254\u2013275","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"2397_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16(3):233\u2013271","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"9","key":"2397_CR10","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.amjcard.2017.07.061","volume":"120","author":"H Hioki","year":"2017","unstructured":"Hioki H, Watanabe Y, Kozuma K, Nara Y, Kawashima H, Nagura F, Nakashima M, Kataoka A, Yamamoto M, Naganuma T, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K, Investigators O-T (2017) Timing of susceptibility to mortality and heart failure in patients with preexisting atrial fibrillation after transcatheter aortic valve implantation. Am J Cardiol 120(9):1618\u20131625","journal-title":"Am J Cardiol"},{"issue":"11","key":"2397_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.amjcard.2018.08.036","volume":"122","author":"P Guedeney","year":"2018","unstructured":"Guedeney P, Chieffo A, Snyder C, Mehilli J, Petronio AS, Claessen BE, Sartori S, Lefevre T, Presbitero P, Capranzano P (2018) Impact of baseline atrial fibrillation on outcomes among women who underwent contemporary transcatheter aortic valve implantation (from the Win-TAVI registry). Am J Cardiol 122(11):1909\u20131916","journal-title":"Am J Cardiol"},{"issue":"3","key":"2397_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jtcvs.2021.11.055","volume":"166","author":"M Kubala","year":"2023","unstructured":"Kubala M, Bohbot Y, Rusinaru D, Marechaux S, Diouf M, Tribouilloy C (2023) Atrial fibrillation in severe aortic stenosis: prognostic value and results of aortic valve replacement. J Thorac Cardiovasc Surg 166(3):771\u2013779","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"2397_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, Testani JM, Tang WW, Orso F, Rossignol P (2019) The use of diuretics in heart failure with congestion\u2014a position statement from the heart failure association of the European society of cardiology. Eur J Heart Fail 21(2):137\u2013155","journal-title":"Eur J Heart Fail"},{"issue":"12 Suppl 1","key":"2397_CR14","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.amjmed.2006.09.014","volume":"119","author":"JG Cleland","year":"2006","unstructured":"Cleland JG, Coletta A, Witte K (2006) Practical applications of intravenous diuretic therapy in decompensated heart failure. Am J Med 119(12 Suppl 1):S26-36","journal-title":"Am J Med"},{"issue":"10","key":"2397_CR15","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.amjcard.2019.08.018","volume":"124","author":"P Pellicori","year":"2019","unstructured":"Pellicori P, Urbinati A, Kaur K, Zhang J, Shah P, Kazmi S, Capucci A, Cleland JGF, Clark AL (2019) Prevalence and Incidence of atrial fibrillation in ambulatory patients with heart failure. Am J Cardiol 124(10):1554\u20131560","journal-title":"Am J Cardiol"},{"issue":"3","key":"2397_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","volume":"8","author":"ZL Cox","year":"2020","unstructured":"Cox ZL, Hung R, Lenihan DJ, Testani JM (2020) Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T trial. JACC Heart Fail 8(3):157\u2013168","journal-title":"JACC Heart Fail"},{"issue":"11","key":"2397_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207481","volume":"13","author":"H Takimura","year":"2018","unstructured":"Takimura H, Hada T, Kawano M, Yabe T, Takimura Y, Nishio S, Nakano M, Tsukahara R, Muramatsu T (2018) A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan. PLoS ONE 13(11):e0207481","journal-title":"PLoS ONE"},{"key":"2397_CR18","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/293938","volume":"2011","author":"M Sarraf","year":"2011","unstructured":"Sarraf M, Schrier RW (2011) Cardiorenal syndrome in acute heart failure syndromes. Int J Nephrol 2011:293938","journal-title":"Int J Nephrol"},{"issue":"19","key":"2397_CR19","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.2169\/internalmedicine.55.7133","volume":"55","author":"T Masuda","year":"2016","unstructured":"Masuda T, Murakami T, Igarashi Y, Okabe K, Kobayashi T, Takeda SI, Saito T, Sekiguchi C, Miyazawa Y, Akimoto T, Saito O, Muto S, Nagata D (2016) Dual impact of tolvaptan on intracellular and extracellular water in chronic kidney disease patients with fluid retention. Intern Med 55(19):2759\u20132764","journal-title":"Intern Med"},{"issue":"10","key":"2397_CR20","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00380-019-01411-3","volume":"34","author":"M Mitsui","year":"2019","unstructured":"Mitsui M, Kataoka A, Nara Y, Nagura F, Kawashima H, Hioki H, Nakashima M, Watanabe Y, Yokoyama N, Kozuma K (2019) Clinical safety and efficacy of tolvaptan for acute phase therapy in patients with low-flow and normal-flow severe aortic stenosis. Heart Vessel 34(10):1684\u20131691","journal-title":"Heart Vessel"},{"issue":"3","key":"2397_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12928-019-00621-w","volume":"35","author":"H Onoda","year":"2020","unstructured":"Onoda H, Ueno H, Ueno Y, Kuwahara H, Sobajima M, Kinugawa K (2020) The impact of changes in B-type natriuretic peptide levels on prognosis after transcatheter aortic valve implantation. Cardiovasc Interv Ther 35(3):283\u2013290","journal-title":"Cardiovasc Interv Ther"},{"issue":"1","key":"2397_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2739\/kurumemedj.MS671001","volume":"67","author":"K Shimozono","year":"2022","unstructured":"Shimozono K, Fukumoto Y (2022) Effectiveness and safety of tolvaptan in patients with aortic stenosis. Kurume Med J 67(1):11\u201316","journal-title":"Kurume Med J"},{"issue":"6","key":"2397_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cardfail.2016.02.007","volume":"22","author":"Y Matsue","year":"2016","unstructured":"Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR (2016) Clinical effectiveness of tolvaptan in patients with acute heart failure and renal dysfunction. J Card Fail 22(6):423\u2013432","journal-title":"J Card Fail"},{"issue":"1","key":"2397_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1253\/circj.CJ-17-0179","volume":"82","author":"T Inomata","year":"2017","unstructured":"Inomata T, Ikeda Y, Kida K, Shibagaki Y, Sato N, Kumagai Y, Shinagawa H, Ako J, Izumi T, Kanagawa Aquaresis I (2017) Effects of additive tolvaptan vs. increased furosemide on heart failure with diuretic resistance and renal impairment- results from the K-STAR study. Circ J 82(1):159\u2013167","journal-title":"Circ J"},{"issue":"2","key":"2397_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40256-018-0304-1","volume":"19","author":"F Yuan","year":"2019","unstructured":"Yuan F, Wu Z, Jiang L, Zhou J, Xu L, Liu H, Ma L, Zhai Z, Zhang J (2019) Short-term effects of tolvaptan in tricuspid insufficiency combined with left heart valve replacement-caused volume-overload patients: results of a prospective pilot study. Am J Cardiovasc Drugs 19(2):211\u2013218","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"2397_CR26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00380-021-02014-7","volume":"37","author":"T Murakami","year":"2022","unstructured":"Murakami T, Nakamura N, Natsumeda M, Matsumoto S, Sakai K, Ohno Y, Nakazawa G, Shinozaki N, Ikari Y (2022) Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure. Heart Vessel 37(7):1153\u20131161","journal-title":"Heart Vessel"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02397-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02397-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02397-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T19:02:10Z","timestamp":1721588530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02397-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2397"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02397-3","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}